Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4

European Journal of Immunology

Volumn 36, Issue 2, 2006, Pages 457-467

  Zhang, Tianqian ^a   Somasundaram, Rajasekharan ^a   Berencsi, Klara ^a   Caputo, Laura ^a   Gimotty, Phyllis ^b   Rani, Pyapalli ^a   Guerry, DuPont ^c   Swoboda, Rolf ^a   Herlyn, Dorothee ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokines; Chemotaxis; CTL; Tumor apoptosis; Tumor immunity

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR4; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ANTIBODY;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL ADHESION; CELL ASSAY; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGAND BINDING; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL CULTURE TECHNIQUES; CHEMOKINE CCL2; CHEMOTAXIS; FEMALE; HUMANS; MELANOMA; MICE; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 32944459278     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526208     Document Type: Article

References (41)

1. Homey, B., Muller, A. and Zlotnik, A., Chemokines: agents for the immunotherapy of cancer? Nat. Rev. Immunol. 2002. 2: 175-184.
2. Frederick, M. J. and Clayman, G. L., Chemokines in cancer. Expert Rev. Mol. Med. 2001. 2001: 1-18.
3. Vicari, A. P. and Caux, C., Chemokines in cancer. Cytokine Growth Factor Rev. 2002. 13: 143-154.
4. Biragyn, A. and Kwak, L. W., Designer cancer vaccines are still in fashion. Nat. Med. 2000. 6: 966-968.
5. Biragyn, A., Tani, K., Grimm, M. C., Weeks, S. and Kwak, L. W., Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nat. Biotechnol 1999. 17: 253-258.
6. Banner, B. F., Savas, L. and Woda, B. A., Expression of adhesion molecules in the host response to colon carcinoma. Ultrastruct. Pathol. 1995. 19: 113-118.
7. + T lymphocytes migrating in three-dimensional collagen lattices lack focal adhesions and utilize beta1 integrin-independent strategies for polarization, interaction with collagen fibers and locomotion. Eur. J. Immunol. 1998. 28: 2331-2343.
8. Rao, W. H., Hales, J. M. and Camp, R. D., Potent costimulation of effector T lymphocytes by human collagen type I. J. Immunol. 2000. 165: 4935-4940.
9. Murakami, S. and Okada, H., Lymphocyte-fibroblast interactions. Crit. Rev. Oral Biol. Med. 1997. 8: 40-50.
10. Maaser, K., Wolf, K., Klein, C. E., Niggemann, B., Zanker, K. S., Brocker, E. B. and Friedl, P., Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices. Mol. Biol. Cell 1999. 10: 3067-3079.
11. Binnerts, M. E., van Kooyk, Y., Simmons, D. L. and Figdor, C. G., Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1. Eur. J. Immunol. 1994. 24: 2155-2160.
12. Crowston, J. G., Salmon, M., Khaw, P. T. and Akbar, A. N., T-lymphocyte-fibroblast interactions. Biochem. Soc. Trans. 1997. 25: 529-531.
13. Maas-Szabowski, N., Stark, H. J. and Fusenig, N. E., Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 2000. 114: 1075-1084.
14. Starnes, H. F., Jr., Biological effects and possible clinical applications of interleukin 1. Semin. Hematol. 1991. 28: 34-41.
15. Rathmell, J. C., Farkash, E. A., Gao, W. and Thompson, C. B., IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 2001. 167: 6869-6876.
16. Wei, W. Z., Miller, B. and Gutierrez, R. M., Inhibition of tumor growth by peptide specific cytotoxic T lymphocytes in a three-dimensional collagen matrix. J. Immunol. Methods 1997 200: 47-54.
17. Jacobs, N., Moutschen, M. P., Franzen-Detrooz, E., Boniver, V., Boniver, J. and Delvenne, P., Organotypic culture of HPV-transformed keratinocytes: a model for testing lymphocyte infiltration of (pre)neoplastic lesions of the uterine cervix. Virchows Arch. 1998. 432: 323-330.
18. Tasaki, A., Yamanaka, N., Kubo, M., Matsumoto, K., Kuroki, H., Nakamura, K., Nakahara, C. et al., Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells. J. Immunol. Methods 2004. 287: 79-90.
19. Zhang, T., Somasundaram, R., Berencsi, K., Caputo, L., Rani, P., Guerry, D., Furth, E. et al., CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture. J. Immunol. 2005. 174: 5856-5863.
20. Graves, D. T., Barnhill, R., Galanopoulos, T. and Antoniades, H. N., Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 1992. 140: 9-14.
21. Nesbit, M., Schaider, H., Miller, T. H. and Herlyn, M., Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J. Immunol. 2001. 166: 6483-6490.
22. Matsushima, K., Larsen, C. G., DuBois, G. C. and Oppenheim, J. J., Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 1989. 169: 1485-1490.
23. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., Kuratsu, J. and Leonard, E. J., Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 1989. 169: 1449-1459.
24. 2+ mobilization, and enzyme release. J. Immunol. 1996. 156: 322-327.
25. Carr, M. W., Roth, S. J., Luther, E., Rose, S. S. and Springer, T. A., Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 1994. 91: 3652-3656.
26. Power, C. A., Meyer, A., Nemeth, K., Bacon, K. B., Hoogewerf, A. J., Proudfoot, A. E. and Wells, T. N., Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 1995. 270: 19495-19500.
27. Ishida, T., Utsunomiya, A., Iida, S., Inagaki, H., Takatsuka, Y., Kusumoto, S., Takeuchi, G. et al., Clinical significance of CCR4 expression in adult T -cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin. Cancer Res. 2003. 9: 3625-3634.
28. Balkwill, F., Cancer and the chemokine network. Nat. Rev. Cancer 2004. 4: 540-550.
29. Ghia, P., Transidico, P., Veiga, J. P., Schaniel, C., Sallusto, F., Matsushima, K., Sallan, S. E. et al., Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells. Blood 2001. 98: 533-540.
30. Hoogewerf, A., Black, D., Proudfoot, A. E., Wells, T. N. and Power, C. A., Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. Biochem. Biophys. Res. Commun. 1996. 218: 337-343.
31. Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S. and Yoshie, O., The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 1997. 272: 15036-15042.
32. Manome, Y., Wen, P. Y., Hershowitz, A., Tanaka, T., Rollins, B. J., Kufe, D. W. and Fine, H. A., Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 1995. 41: 227-235.
33. Clemente, C. G., Mihm, M. C. Jr., Bufalino, R., Zurrida, S., Collini, P. and Cascinelli, N., Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996. 77: 1303-1310.
34. Mullins, I. M., Slingluff, C. L., Lee, J. K., Garbee, C. F., Shu, J., Anderson, S. G., Mayer, M. E. et al., CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease. Cancer Res. 2004. 64: 7697-7701.
35. Somasundaram, R., Swoboda, R., Caputo, L., Lee, A., Jackson, N., Marincola, F. M., Guerry, D. and Herlyn, D., A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma. Int. J. Cancer 2003. 104: 362-368.
36. Somasundaram, R., Robbins, P., Moonka, D., Loh, E., Marincola, F., Patel, A., Guerry, D. and Herlyn, D., CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells. Int. J. Cancer 2000. 85: 253-259.
37. Horikawa, T., Nakayama, T., Hikita, I., Yamada, H., Fujisawa, R., Bito, T., Harada, S. et al., IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int. Immunol. 2002. 14: 767-773.
38. Bourcier, T., Berbar, T., Paquet, S., Rondeau, N., Thomas, F., Borderie, V., Laroche, L. et al., Characterization and functionality of CXCR4 chemokine receptor and SDF-1 in human corneal fibroblasts. Mol. Vis. 2003. 9: 96-102.
39. Kim, C. H., Pelus, L. M., White, J. R. and Broxmeyer, H. E., Macrophage-inflammatory protein-3 beta/EBI1-ligand chemokine/CK beta-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells. J. Immunol. 1998. 161: 2580-2585.
40. Jacob, L., Somasundaram, R., Smith, W., Monos, D., Basak, S., Marincola, F., Pereira, S. and Herlyn, D., Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. Int. J. Cancer 1997. 71: 325-332.
41. Duan, W. R., Garner, D. S., Williams, S. D., Funckes-Shippy, C. L., Spath, I. S. and Blomme, E. A., Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J. Pathol. 2003. 199: 221-228.